Moreover, by introducing a phosphomimetic mutation at S536(p65/S536D), nuclear NF‐κB can overcome anticancer therapy resistance by inducing apoptosis and senescence,18, 19 further implicating S536 phosphorylation in a tumour‐suppressive role. Here, NFKB1 is linked to neoplasm.